Being a shareholder in TIS the past few months has been frustrating for all of us with the unachieved timeframes we have been given for this to be approved. However, if I look at the positives of this product I feel that it will be a winner. The Vitrogro website is now showing some of the results that this product has achieved. Go to Resources, then Case Studies and it is pretty impressive, especially case study 3. As shareholders we are frustrated but imagine if you are a patient with one of these ulcers that you have had for over 80 months and this could heal it for you in 9 weeks. Wow. Anyway, for everyone sake lets hope this is approved ASAP
TIS Price at posting:
40.0¢ Sentiment: LT Buy Disclosure: Held
